Subcutaneous injection (compounded prescription) Published clinical protocols report typical dose ranges of 1 to 3 mg subcutaneously, administered daily or several times per week, adjusted for the individual patient by their prescribing provider
The 2 mL volume produces concentrations (2.5, 5, 10, 15 mg/mL) that put common doses on multiples of 10 units
If CagriSema truly prevents the metabolic slowdown associated with weight loss, as the preclinical data suggests, it could produce more durable outcomes with less weight regain after treatment completion
Finasteride Mechanism: Finasteride blocks the conversion of testosterone into dihydrotestosterone (DHT), the hormone responsible for follicle miniaturization in androgenic alopecia
Based on current research and practical experience from health professionals, several timing strategies have emerged as most effective